Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial

Journal of Pediatrics

Volumn 134, Issue 3, 1999, Pages 287-292

  Cohen, Ralph C ^a,b,c,d   O'Loughlin, Edward V ^a,b,c,d   Davidson, Geoffrey P ^a,b,c,d   Moore, D J ^a,b,c,d   Lawrence, Diana M ^a,b,c,d  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INFANT; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 0033500145     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70451-8     Document Type: Article

References (11)

1. 1. Orenstein S. Gastroesophageal reflux. Curr Prob Pediatr 1991;21:193-241.
2. 2. Vandenplas Y, Ashkenazi A, Belli D, Boige N, Bouquet J, Cadranel S, et al. A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastroenterology and Nutrition (ESPGAN). Eur J Pediatr 1993;152:704-11.
3. 3. Cucchiara S. Cisapride therapy for gastrointestinal disease. J Pediatr Gastroenterol Nutr 1996;22:259-69.
4. 4. Pope CE II. Current concepts: acid-reflux disorders. N Engl J Med 1994; 331:656-60.
5. 5. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995;333:1106-10.
6. 6. Cucchiara S, Staiano A, Boccieri A, De Stefano M, Capozzi C, Manzi G, et al. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease. Gut 1990;31:21-5.
7. 7. Greally P, Hampton FJ, MacFadyen UM, Simpson H. Gaviscon and Carobel compared with cisapride in gastrooesophageal reflux. Arch Dis Child 1992;67:618-21.
8. 8. Vandenplas Y, de Roy C, Sacre L. Cisapride decreases prolonged episodes of reflux in infants. J Pediatr Gastroenterol Nutr 1991;12:44-7.
9. 9. Scott RB, Ferriera C, Smith L, Jones AB, Machida H, Lohoues MJ, et al. Cisapride in pediatric gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1997;25:499-506.
10. 10. Strobel CT, Byrne WJ, Ament ME, Euler AR. Correlation of esophageal length in children with height: application of the Tuttle test without prior esophageal manometry. J Pediatr 1979;94:81-4.
11. 11. Euler AR, Byrne WJ. Twenty-four hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology 1981;80:957-61.